Doctors must monitor
patients’ progress closely
For many years, the drug class known as
bisphosphonates has been used to treat
osteoporosis.
Their use has been widely
accepted as clinicians moved away from
hormone therapy in the last 10 to 15 years,...
More
Doctors must monitor
patients’ progress closely
For many years, the drug class known as
bisphosphonates has been used to treat
osteoporosis.
Their use has been widely
accepted as clinicians moved away from
hormone therapy in the last 10 to 15 years,
but health care leaders now recognize the
potential harm of using these medications
for a prolonged period.
Research
presented by the FDA is very important
and will lead to more careful consideration
of this therapy in treating bone loss.
Bone health
Bone remodeling is the process by which
the skeleton maintains health and
involves the processes of bone growth
and resorption.
Role-specific cells within
the skeleton known as osteoclasts and
osteoblasts are constantly breaking down
portions of bone and then following up
with newer, stronger replacements.
When stimulated to an area of skeleton
in need of repair, osteoclasts cause a
breakdown of bone and then osteoblasts
“Bisphosphonates
are widely used for
Less
